News Adira to Use $750K Grant to Improve MS Care in Rural Areas of 4 US States Adira to Use $750K Grant to Improve MS Care in Rural Areas of 4 US States by Mary Chapman | October 21, 2021 Share this article: Share article via email Copy article link The Adira FoundationĀ received nearly $750,000 from the Bristol Myers Squibb Foundation to improve care and access for the roughly 5,000 multiple sclerosis (MS) patients living in rural areas of Maryland, North Carolina, Virginia, and West Virginia. Intended to enhance the access and delivery of specialized care to these underserved patients, the foundation will use the three-year grant to bring together a coalition of community stakeholders to offer services that include early health screenings and expanded telehealth. It will also canvass the residents to determine other pressing needs. The initiative aims to set in place a care model that will continue to help rural residents with MS in these four states and, ultimately, in other states as well afterĀ the grant period ends in 2024. Recommended Reading February 10, 2021 News by Hawken Miller Adira Foundation Arises From Life-altering Accident to Help Those With Chronic Ills āPeople living with MS in rural communities face a number of unique barriers that can delay diagnosis and optimal disease management and impact a patientās quality of life,ā John Damonti, president of the Bristol Myers Squibb Foundation, said in a press release. āWe are proud to support the work of Adira Foundation to build an innovative care and community engagement model in these regions with the goal of helping patients in these begins better navigate their MS experience,ā added Damonti. To link rural patients to health specialists and social support programs, the project will also seek to improve a network navigation tool for neurodegenerative diseases that was piloted in Virginia. The tool is accessible offline for people in areas with unreliable internet connectivity. āThis project allows us to help people with multiple sclerosis, but it also helps us take MS out of isolation,ā said Greg Smiley, Adira’s founder and CEO. āBoth goals are important.” MS symptoms are often not specific to that disorder, he added. “People struggling with those symptoms could have MS, or they may have another issue ā perhaps a different neurodegenerative condition,” Smiley added. “We take on those many common concerns people contending with these diseases face. Here that might include a late or misdiagnosis, navigating options, or linking to specialists and treatment clinics far away.ā Adira, a nonprofit, works to improve the lives of people with any of five neurodegenerative diseases: MS, amyotrophic lateral sclerosisĀ (ALS), Parkinsonās, Alzheimer’s, orĀ Huntington’s disease. To achieve its goals, Adira plans to run a chain of diagnostic screening events, and to have patients test and assess its network map tool ā a web-based and searchable map of organizations that serve neurodegenerative disease communities. Adira will also establish partnerships to reach minority and other underserved populations in the rural communities, and offer local health events. With assistance from local health workers, Adira will enlist neurology specialists and movement disorder clinics to help screen for MS in rural areas. It hopes that others will step up to screen individuals who may have a different neurodegenerative disease, and help to pay for interventions. āWe also hope screening not only for MS but for movement disorders more broadly is even more compelling for community-based organizations to participate in and support,ā Smiley said.Ā āNavigating complex health challenges like multiple sclerosis can be crushing, particularly when specialty care is far away.ā Print This Page About the Author Mary Chapman Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. Sheās won a Society of Professional Journalists award for outstanding reporting. Tags telehealth
February 13, 2024 News by Lindsey Shapiro, PhD Nitric oxide metabolites in blood could aid diagnosis of MS: Study
January 24, 2024 News by Andrea Lobo, PhD Healthcare utilization increases in the year before MS diagnosis: Study
December 20, 2023 News by Margarida Maia, PhD Telehealth intervention seen to help MS patients lose weight in trial